Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: Results from the National Survey of Mental Health and Wellbeing

Drug and Alcohol Dependence

Volumn 63, Issue 2, 2001, Pages 147-153

  Swift, Wendy ^a   Hall, Wayne ^a   Teesson, Maree ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australian adults; Cannabis dependence; DSM IV; ICD 10

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; DRUG WITHDRAWAL; HUMAN; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; SYMPTOM;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 0035400731     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(00)00197-6     Document Type: Article

References (51)

1. Aceto M.D., Scates S.M., Lowe J.A., Martin B.R. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur. J. Pharmacol. 282:1995;R1-R2.
2. Andrews G., Hall W., Teesson M., Henderson S. The Mental Health of Australians. 1999;Mental Health Branch, Commonwealth Department of Health and Family Services, Canberra. National Survey of Mental Health and Wellbeing Report 2.
3. Anthony J.C., Helzer J.E. Syndromes of drug abuse and dependence. Robins L.N., Regier D.A. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. 1991;116-154 Free Press, Macmillan, New York.
4. Anthony J.C., Trinkoff A.M. United States epidemiological data on drug use and abuse: how are they relevant to testing abuse reliability on drugs? Fischman M.W., Mello N.K. Testing for Abuse Liability of Drugs in Humans. 1989;241-266 National Institute on Drug Abuse, Rockville, MD. Research Monograph No. 92.
5. Anthony J.C., Warner L.A., Kessler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2:1994;244-268.
6. National Survey of Mental Health and Wellbeing of Adults: Users' Guide. 1998;Australian Bureau of Statistics, Canberra.
7. Budney A.J., Radonovich K.J., Higgins S.T., Wong C. Adults seeking treatment for marijuana dependence: a comparison to cocaine-dependent treatment-seekers. Exp. Clin. Psychopharmacol. 6:1998;419-426.
8. Budney A.J., Novy P.L., Hughes J.R. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 94:1999;1311-1321.
9. Chick J. Is there a unidimensional alcohol dependence syndrome? Br. J. Addict. 75:1980;265-280.
10. Cohen J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 20:1960;37-46.
11. Compton W.M., Cottler L.B., Dorsey K.B., Spitznagel E.L., Mager D.E. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend. 41:1996;179-187.
12. Compton W.M., Cottler L.B., Dorsey K.B., Spitznagel E.L., Mager D.E. Structured and semi-structured assessment of ICD-10 substance dependence disorders: CIDI-SAM vs. SCAN. Int. J. Methods Psychiatr. Res. 6:1996;285-293.
13. Copeland J., Rees V., Swift W. Help seeking among a sample entering treatment for cannabis dependence. Aust. Fam. Physician. 28:1999;540-541. Letter to the Editor.
14. Copeland, J., Swift, W., Rees, V., 2000. Clinical profile of participants in a brief intervention program for cannabis use disorder Journal of Substance Abuse Treatment (in press).
15. Cottler L.B., Helzer J.E., Mager D., Spitznagel E.L., Compton W.M. Agreement between DSM-III and III-R substance use disorders. Drug Alcohol Depend. 29:1991;17-25.
16. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika. 16:1951;297-334.
17. Edwards G., Arif A., Hodgson R. Nomenclature and classification of drug- and alcohol-related problems: a WHO memorandum. Bull. Who. 59:1981;225-242.
18. Feingold A., Rounsaville B. Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances. Addiction. 90:1995;1661-1669.
19. Georgotas A., Zeidenberg P. Observations on the effects of 4 weeks of heavy marijuana smoking on group interaction and individual behavior. Compr. Psychiatry. 20:1979;427-432.
20. Hair J.F., Anderson R.E., Tatham R.L., Black W.C. Multivariate Data Analysis with Readings. fourth ed :1995;Prentice-Hall, Englewood Cliffs, NJ.
21. Hall W., Teesson M., Lynskey M., Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and WellBeing. Addiction. 94:1999;1541-1550.
22. Haney M., Ward A.S., Comer S.D., Foltin R.W., Fischman M.W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology. 141:1999;385-394.
23. Hasin D.S., Grant B.F., Harford T.C., Endicott J. The drug dependence syndrome and related disabilities. Br. J. Addict. 83:1988;45-55.
24. Hasin D., Grant B.F., Cottler L., Blaine J., Towle L., Üstün B., Sartorius N. Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study. Drug Alcohol Depend. 47:1997;217-226.
25. Johnson E.O., Breslau N., Anthony J.C. The latent dimensionality of DIS/DSM-III-R nicotine dependence. Addiction. 91:1996;583-588.
26. Jones R.T., Benowitz N., Herning R.I. The clinical relevance of cannabis tolerance and dependence. J. Clin. Pharmacol. 21:1981;143S-152S.
27. Kandel D., Chen K., Warner L.A., Kessler R.C., Grant B. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the US population. Drug Alcohol Depend. 44:1997;11-29.
28. Kosten T.R., Rounsaville B.J., Babor T.F., Spitzer R.L., Williams J.B.W. Substance-use disorders in DSM-III-R. Br. J. Psychiatry. 151:1987;834-843.
29. Morgenstern J., Langenbucher J., Labouvie E.W. The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction. 89:1994;1105-1113.
30. Muthén B.O., Grant B., Hasin D. The dimensionality of alcohol abuse and dependence: factor analysis of DSM-III-R and proposed DSM-IV criteria in the 1988 National Health Interview Survey. Addiction. 88:1993;1079-1090.
31. Muthén B.O., Hasin D., Wisnicki K.S. Factor analysis of ICD-10 symptom items in the 1988 National Health Interview Survey on Alcohol Dependence. Addiction. 88:1993;1071-1077.
32. Nelson C.B., Rehm J., Üstün B., Grant B., Chatterji S. Factor structure for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction. 94:1999;843-856.
33. Nunnally J.C. Psychometric Theory. 1967;McGraw-Hill, New York.
34. Phillips G.T., Gossop M., Edwards G., Sutherland G., Taylor C., Strang J. The application of the SODQ to the measurement of the severity of opiate dependence in a British sample. Br. J. Addict. 82:1987;691-699.
35. Rapaport M.H., Tipp J.E., Schuckit M.A. A comparison of ICD-10 and DSM-III-R criteria for substance abuse and dependence. Am. J. Drug Alcohol Abuse. 19:1993;143-151.
36. Rounsaville B.J., Bryant K., Babor T., Kranzler H., Kadden R. Cross-system agreement for substance use disorders. Addiction. 88:1993;337-348.
37. Rubino T., Patrini G., Massi P., Fuzio D., Viganò D., Giagnoni G., Parolaro D. Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J. Pharmacol. Exp. Ther. 285:1998;813-819.
38. Shah B.V., Barnwell B.G., Bieler G.S. SUDAAN User's Manual, Release 7.5. 1997;Research Triangle Institute, Research Triangle Park, NC.
39. Spitznagel E.L., Helzer J.E. A proposed solution to the base rate problem in the kappa statistic. Arch. Gen. Psychiatry. 42:1985;725-728.
40. SPSS for Windows, Base System User's Guide, Release 6.1.4. 1993;SPSS, Chicago.
41. Stephens R.S., Roffman R.A., Simpson E.E. Adult marijuana users seeking treatment. J. Consult. Clin. Psychol. 61:1993;1100-1104.
42. Stephens, R.S., Roffman, R.A., Curtin, L., 2000. Comparison of extended versus brief treatment for marijuana use. J. Consult. Clin. Psychol. (in press).
43. Streiner D.L., Norman G.R. Health Measurement Scales: A Practical Guide to Their Development and Use. second ed :1995;Oxford University Press, Oxford.
44. Swift W., Hall W., Didcott P., Reilly D. Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction. 93:1998;1149-1160.
45. Swift W., Hall W., Teesson M. Cannabis Use Disorders among Australian Adults: Findings from the National Survey of Mental Health and Wellbeing. 1999;National Drug and Alcohol Research Centre, Sydney. Technical Report No. 78.
46. Swift W., Hall W., Copeland J. One year follow-up of cannabis dependence among long-term cannabis users in Sydney, Australia. Drug Alcohol Depend. 59:2000;309-318.
47. SYSTAT for DOS: Advanced Applications, Version 6 edition. 1994;SYSTAT, Evanston, IL.
48. SYSTAT for DOS: Using SYSTAT, Version 6 edition. 1994;SYSTAT, Evanston, IL.
49. Wiesbeck G.A., Schuckit M.A., Kalmijn J.A., Tipp J.E., Bucholz K.K., Smith T.L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 91:1996;1469-1478.
50. Composite International Diagnostic Interview (CIDI) Core Version 2.1, 12-Month Version. 1997;World Health Organization, Geneva.
51. Yule G.U. On the methods of measuring association between two attributes. J. R. Stat. Soc. 75:1912;581-642.